Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06557252
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-12
Brief Title:
The Application of the PDCA Management Model in Improving the Diagnostic Accuracy of AIG
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Application of the PDCA Management Model in Improving the Diagnostic Accuracy of AIG
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Autoimmune gastritis is currently relatively rare in China due to its insidious onset diverse clinical manifestations involving multiple systems such as digestive hematological and nervous systems and its association with other autoimmune diseases It can also be complicated by hyperplastic gastric polyps gastric neuroendocrine tumors gastric adenocarcinoma and other diseases making it prone to clinical misdiagnosis As a form of gastritis in the post-Helicobacter pylori era its detection rate has been gradually increasing with the continuous improvement of endoscopic technology in China Applying the PDCA cycle management in disease diagnosis can significantly improve the detection rate of the disease benefiting patients Through the PDCA management model this study further enhanced gastroenterologists understanding of this disease from various aspects aiming to improve the clinical diagnosis of autoimmune gastritis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None